Representation, Access, and Inclusion in Clinical Trials: A Patient‐Centered Perspective from the ASCPT 2025 Patient Forum

Clinical Pharmacology & Therapeutics 2026 Open access

Read full text
Authors: Stephani L. Stancil, Ricki Fairley, LaToya Bolds-Johnson, Hope M. Krebill, Barbara E. Bierer
DOI: 10.1002/cpt.70234
Cited by: 0
References: 9

Abstract

Clinical trials drive therapeutic innovation but often underrepresent populations most affected by the disease. Despite efforts to include women, minorities, and children, participation still lags behind intent. Ensuring equitable representation is essential to maximize the impact of new therapies. This perspective offers actionable insights from a diverse panel-including patients, clinicians, researchers, and advocates-shared during the 2025 American Society for Clinical Pharmacology and Therapeutics Patient Forum.

Fields of Study & Subjects

Ethics in Clinical Research Statistical Methods in Clinical Trials Diversity and Career in Medicine

Publication details

Journal / source
Clinical Pharmacology & Therapeutics
Volume
119
Issue
5
Pages
1152–1155
Publication date
10 February 2026
Language
EN